Staphylococcus aureus Leukocidin LukED and HIV-1 gp120 Target Different Sequence Determinants on CCR5
Leukocidin ED (LukED) is a bicomponent pore-forming toxin produced by Staphylococcus aureus that lyses host cells by targeting the chemokine receptors CC chemokine receptor type 5 (CCR5), CXCR1, CXCR2, and DARC. In addition to its role as a receptor for LukED, CCR5 is the major coreceptor for primar...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2016-12-01
|
Series: | mBio |
Online Access: | http://mbio.asm.org/cgi/content/full/7/6/e02024-16 |
id |
doaj-3c8785e3d3314bd98c47f2e89dd46cb0 |
---|---|
record_format |
Article |
spelling |
doaj-3c8785e3d3314bd98c47f2e89dd46cb02021-07-02T13:29:49ZengAmerican Society for MicrobiologymBio2150-75112016-12-0176e02024-1610.1128/mBio.02024-16Staphylococcus aureus Leukocidin LukED and HIV-1 gp120 Target Different Sequence Determinants on CCR5Kayan TamMegan SchultzTamara Reyes-RoblesBénéédicte VanwalscappelJoshua HortonFrancis AlonzoBeili WuNathaniel R. LandauVictor J. TorresLeukocidin ED (LukED) is a bicomponent pore-forming toxin produced by Staphylococcus aureus that lyses host cells by targeting the chemokine receptors CC chemokine receptor type 5 (CCR5), CXCR1, CXCR2, and DARC. In addition to its role as a receptor for LukED, CCR5 is the major coreceptor for primary isolates of human immunodeficiency virus type 1 (HIV-1) and has been extensively studied. To compare how LukED and HIV-1 target CCR5, we analyzed their respective abilities to use CCR5/CCR2b chimeras to mediate cytotoxicity and virus entry. These analyses showed that the second and third extracellular loops (ECL) of CCR5 are necessary and sufficient for LukED to target the receptor and promote cell lysis. In contrast, the second ECL of CCR5 is necessary but not sufficient for HIV-1 infectivity. The analysis of CCR5 point mutations showed that glycine-163 is critical for HIV-1 infectivity, while arginine-274 and aspartic acid-276 are critical for LukED cytotoxicity. Point mutations in ECL2 diminished both HIV-1 infectivity and LukED cytotoxicity. Treatment of cells with LukED did not interfere with CCR5-tropic HIV-1 infectivity, demonstrating that LukED and the viral envelope glycoprotein use nonoverlapping sites on CCR5. Analysis of point mutations in LukE showed that amino acids 64 to 69 in the rim domain are required for CCR5 targeting and cytotoxicity. Taking the results together, this study identified the molecular basis by which LukED targets CCR5, highlighting the divergent molecular interactions evolved by HIV-1 and LukED to interact with CCR5.http://mbio.asm.org/cgi/content/full/7/6/e02024-16 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Kayan Tam Megan Schultz Tamara Reyes-Robles Bénéédicte Vanwalscappel Joshua Horton Francis Alonzo Beili Wu Nathaniel R. Landau Victor J. Torres |
spellingShingle |
Kayan Tam Megan Schultz Tamara Reyes-Robles Bénéédicte Vanwalscappel Joshua Horton Francis Alonzo Beili Wu Nathaniel R. Landau Victor J. Torres Staphylococcus aureus Leukocidin LukED and HIV-1 gp120 Target Different Sequence Determinants on CCR5 mBio |
author_facet |
Kayan Tam Megan Schultz Tamara Reyes-Robles Bénéédicte Vanwalscappel Joshua Horton Francis Alonzo Beili Wu Nathaniel R. Landau Victor J. Torres |
author_sort |
Kayan Tam |
title |
Staphylococcus aureus Leukocidin LukED and HIV-1 gp120 Target Different Sequence Determinants on CCR5 |
title_short |
Staphylococcus aureus Leukocidin LukED and HIV-1 gp120 Target Different Sequence Determinants on CCR5 |
title_full |
Staphylococcus aureus Leukocidin LukED and HIV-1 gp120 Target Different Sequence Determinants on CCR5 |
title_fullStr |
Staphylococcus aureus Leukocidin LukED and HIV-1 gp120 Target Different Sequence Determinants on CCR5 |
title_full_unstemmed |
Staphylococcus aureus Leukocidin LukED and HIV-1 gp120 Target Different Sequence Determinants on CCR5 |
title_sort |
staphylococcus aureus leukocidin luked and hiv-1 gp120 target different sequence determinants on ccr5 |
publisher |
American Society for Microbiology |
series |
mBio |
issn |
2150-7511 |
publishDate |
2016-12-01 |
description |
Leukocidin ED (LukED) is a bicomponent pore-forming toxin produced by Staphylococcus aureus that lyses host cells by targeting the chemokine receptors CC chemokine receptor type 5 (CCR5), CXCR1, CXCR2, and DARC. In addition to its role as a receptor for LukED, CCR5 is the major coreceptor for primary isolates of human immunodeficiency virus type 1 (HIV-1) and has been extensively studied. To compare how LukED and HIV-1 target CCR5, we analyzed their respective abilities to use CCR5/CCR2b chimeras to mediate cytotoxicity and virus entry. These analyses showed that the second and third extracellular loops (ECL) of CCR5 are necessary and sufficient for LukED to target the receptor and promote cell lysis. In contrast, the second ECL of CCR5 is necessary but not sufficient for HIV-1 infectivity. The analysis of CCR5 point mutations showed that glycine-163 is critical for HIV-1 infectivity, while arginine-274 and aspartic acid-276 are critical for LukED cytotoxicity. Point mutations in ECL2 diminished both HIV-1 infectivity and LukED cytotoxicity. Treatment of cells with LukED did not interfere with CCR5-tropic HIV-1 infectivity, demonstrating that LukED and the viral envelope glycoprotein use nonoverlapping sites on CCR5. Analysis of point mutations in LukE showed that amino acids 64 to 69 in the rim domain are required for CCR5 targeting and cytotoxicity. Taking the results together, this study identified the molecular basis by which LukED targets CCR5, highlighting the divergent molecular interactions evolved by HIV-1 and LukED to interact with CCR5. |
url |
http://mbio.asm.org/cgi/content/full/7/6/e02024-16 |
work_keys_str_mv |
AT kayantam staphylococcusaureusleukocidinlukedandhiv1gp120targetdifferentsequencedeterminantsonccr5 AT meganschultz staphylococcusaureusleukocidinlukedandhiv1gp120targetdifferentsequencedeterminantsonccr5 AT tamarareyesrobles staphylococcusaureusleukocidinlukedandhiv1gp120targetdifferentsequencedeterminantsonccr5 AT beneedictevanwalscappel staphylococcusaureusleukocidinlukedandhiv1gp120targetdifferentsequencedeterminantsonccr5 AT joshuahorton staphylococcusaureusleukocidinlukedandhiv1gp120targetdifferentsequencedeterminantsonccr5 AT francisalonzo staphylococcusaureusleukocidinlukedandhiv1gp120targetdifferentsequencedeterminantsonccr5 AT beiliwu staphylococcusaureusleukocidinlukedandhiv1gp120targetdifferentsequencedeterminantsonccr5 AT nathanielrlandau staphylococcusaureusleukocidinlukedandhiv1gp120targetdifferentsequencedeterminantsonccr5 AT victorjtorres staphylococcusaureusleukocidinlukedandhiv1gp120targetdifferentsequencedeterminantsonccr5 |
_version_ |
1721328972532285440 |